Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial

F Iannone*, G La Montagna, G Bagnato, Elisa Gremese, A Giardina, G. Lapadula

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

36 Citazioni (Scopus)

Abstract

To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
Lingua originaleInglese
pagine (da-a)286-292
Numero di pagine7
RivistaTHE JOURNAL OF RHEUMATOLOGY
Volume41
Numero di pubblicazione2
DOI
Stato di pubblicazionePubblicato - 2014

All Science Journal Classification (ASJC) codes

  • Immunologia e Allergia
  • Reumatologia
  • Immunologia

Keywords

  • Adult
  • Aged
  • Alanine Transaminase
  • Antirheumatic Agents
  • Arthritis
  • Aspartate Aminotransferases
  • Combination
  • DISEASE ACTIVITY SCORE
  • Drug Therapy
  • Female
  • GISEA
  • HEALTH ASSESSMENT QUESTIONNAIRE
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Immunoglobulin G
  • Liver Function Tests
  • Male
  • Methotrexate
  • Middle Aged
  • Prospective Studies
  • Receptors
  • Rheumatoid
  • Severity of Illness Index
  • TNF-α INHIBITORS
  • TRANSAMINASES
  • Treatment Outcome
  • Tumor Necrosis Factor
  • Viral Load
  • Virus Replication

Fingerprint

Entra nei temi di ricerca di 'Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial'. Insieme formano una fingerprint unica.

Cita questo